American Journal of Obstetrics & Gynecology
Volume 190, Issue 6 , Pages 1723-1728 , June 2004

Aggressive tocolysis does not prolong pregnancy or reduce neonatal morbidity after preterm premature rupture of the membranes

References 

  1. Olofsson P, Rydhström H, Sjöberg N-O. How Swedish obstetricians manage premature rupture of the membranes in preterm gestations. Am J Obstet Gynecol. 1988;159:1028–1034
  2. Taslimi MM, Sibai BM, Amon E, Taslimi CK, Herrick CN. A national survey on preterm labor. Am J Obstet Gynecol. 1989;160:1352–1360
  3. Capeless EL, Mead PB. Management of preterm premature rupture of membranes: lack of a national consensus. Am J Obstet Gynecol. 1987;157:11–12
  4. Christensen KK, Ingemarsson I, Leideman T, Solum H, Svenningsen N. Effect of ritodrine on labor after premature rupture of the membranes. Obstet Gynecol. 1980;55:187–190
  5. Levy DL, Warsof SL. Oral ritodrine and preterm premature rupture of membranes. Obstet Gynecol. 1985;66:621–623
  6. Garite TJ, Keegan KA, Freeman RK, Nageotte MP. A randomized trial of ritodrine tocolysis versus expectant management in patients with premature rupture of membranes at 25 to 30 weeks of gestation. Am J Obstet Gynecol. 1987;157:388–393
  7. Weiner CP, Renk K, Klugman M. The therapeutic efficacy and cost-effectiveness of aggressive tocolysis for premature labor associated with premature rupture of the membranes. Am J Obstet Gynecol. 1988;159:216–222
  8. How HY, Cook CR, Cook VD, Miles DE, Spinnato JA. Preterm premature rupture of membranes: aggressive tocolysis versus expectant management. J Matern Fetal Med. 1998;7:8–12
  9. Decavalas G, Mastrogiannis D, Papadopoulos V, Tzingounis V. Short-term versus long-term prophylactic tocolysis in patients with preterm premature rupture of membranes. Eur J Obstet Gynecol Reprod Biol. 1995;59:143–147
  10. Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Ramsey RD, et al.  Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes: a randomized controlled trial. JAMA. 1997;278:989–995
  11. Amon E, Lewis SV, Sibai BM, Villar MA, Arheart KL. Ampicillin prophylaxis in preterm premature rupture of the membranes: a prospective randomized study. Am J Obstet Gynecol. 1988;159:539–543
  12. McGregor JA, French JI, Seo K. Antimicrobial therapy in preterm premature rupture of membranes: results of a prospective, double-blind, placebo-controlled trial of erythromycin. Am J Obstet Gynecol. 1991;165:632–640
  13. Grable IA, Garcia PM, Perry D, Socol ML. Group B Streptococcus and preterm premature rupture of membranes: a randomized, double-blind clinical trial of antepartum ampicillin. Am J Obstet Gynecol. 1996;175:1036–1042

☆ Presented at the Seventieth Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, September 17-21, 2003, Anchorage, Alaska.

PII: S0002-9378(04)00205-4

doi: 10.1016/j.ajog.2004.02.042

American Journal of Obstetrics & Gynecology
Volume 190, Issue 6 , Pages 1723-1728 , June 2004

Article Tools

* Image Usage & Resolution